Janus Henderson Group PLC Vaxcyte, Inc. Transaction History

Janus Henderson Group PLC

$194 Billion
Q2 2025

A detailed history of Janus Henderson Group PLC transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 14,691,344 shares of PCVX stock, worth $655 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

14,691,344

Previous 11,765,481 24.87%

Holding current value

$655 Million

Previous $444 Million 7.51%

% of portfolio

0.25%

Previous 0.25%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$28.04 - $37.2 $82 Million - $109 Million	2,925,863 Added 24.87%	14,691,344 $478 Million
Q1 2025 May 15, 2025	BUY	$37.76 - $92.13 $44.9 Million - $110 Million	1,190,118 Added 11.25%	11,765,481 $444 Million
Q4 2024 Feb 14, 2025	SELL	$80.97 - $117.93 $28.1 Million - $40.9 Million	-346,533 Reduced 3.17%	10,575,363 $866 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $145 Million - $240 Million	2,052,989 Added 23.15%	10,921,896 $1.25 Billion
Q2 2024 Aug 14, 2024	BUY	$60.06 - $78.77 $71.8 Million - $94.1 Million	1,195,039 Added 15.57%	8,868,907 $670 Million
Q1 2024 May 15, 2024	BUY	$59.79 - $81.05 $41.4 Million - $56.1 Million	692,492 Added 9.92%	7,673,868 $524 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $3.59 Million - $5.02 Million	-79,212 Reduced 1.12%	6,981,376 $438 Million
Q3 2023 Nov 14, 2023	BUY	$46.0 - $53.1 $38,502 - $44,444	837 Added 0.01%	7,060,588 $360 Million
Q2 2023 Aug 14, 2023	SELL	$34.66 - $54.07 $2.35 Million - $3.67 Million	-67,860 Reduced 0.95%	7,059,751 $353 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $41.8 Million - $54.4 Million	1,153,472 Added 19.31%	7,127,611 $267 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $29.6 Million - $68.9 Million	1,436,388 Added 31.65%	5,974,139 $286 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $6.79 Million - $8.94 Million	313,264 Added 7.42%	4,537,751 $109 Million
Q2 2022 Aug 15, 2022	SELL	$17.68 - $26.58 $1.86 Million - $2.8 Million	-105,277 Reduced 2.43%	4,224,487 $91.9 Million
Q1 2022 May 16, 2022	BUY	$17.46 - $26.36 $1.45 Million - $2.19 Million	83,100 Added 1.96%	4,329,764 $105 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $2.96 Million - $4.05 Million	153,198 Added 3.74%	4,246,664 $101 Million
Q3 2021 Nov 16, 2021	SELL	$20.26 - $26.97 $475,968 - $633,606	-23,493 Reduced 0.57%	4,093,466 $104 Million
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $1.86 Million - $2.73 Million	-113,348 Reduced 2.68%	4,116,959 $92.7 Million
Q1 2021 May 17, 2021	BUY	$18.66 - $29.16 $625,651 - $977,705	33,529 Added 0.8%	4,230,307 $83.5 Million
Q4 2020 Feb 16, 2021	BUY	$26.57 - $51.74 $9,272 - $18,057	349 Added 0.01%	4,196,778 $108 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $14 Million - $29.3 Million	-529,363 Reduced 11.2%	4,196,429 $200 Million
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $124 Million - $168 Million	4,725,792 New	4,725,792 $140 Million

Others Institutions Holding PCVX

# of Institutions

324

Shares Held

139M

Call Options Held

229K

Put Options Held

160K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.64B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Vaxcyte, Inc. Transaction History